2-(2-Phenylethyl)chromone
CAS No. 61828-53-3
2-(2-Phenylethyl)chromone( Flidersiachromone )
Catalog No. M29258 CAS No. 61828-53-3
2-(2-Phenylethyl)chromone is a natural product isolated from the herbs of Aquilaria sinensis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 81 | Get Quote |
|
| 10MG | 126 | Get Quote |
|
| 25MG | 207 | Get Quote |
|
| 50MG | 315 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name2-(2-Phenylethyl)chromone
-
NoteResearch use only, not for human use.
-
Brief Description2-(2-Phenylethyl)chromone is a natural product isolated from the herbs of Aquilaria sinensis.
-
Description2-(2-Phenylethyl)chromone is a natural product isolated from the herbs of Aquilaria sinensis.
-
In Vitro——
-
In Vivo——
-
SynonymsFlidersiachromone
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number61828-53-3
-
Formula Weight250.29
-
Molecular FormulaC17H14O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (399.54 mM)
-
SMILESO=C1c(cccc2)c2OC(CCc2ccccc2)=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
β-Aminoarteether
β-Aminoarteether (SM934 free base), an orally active derivative of Artemisinin, serves a pivotal role in the research of inflammation and autoimmune disorders, including those related to lupus diseases.
-
PKG Substrate
PKG Substrate is a selective substrate for cGMP-dependent protein kinase (PKG).PKG Substrate is a selective substrate for protein kinase G (PKG) with a strong preference for PKG Iα (Km = 59 μM) over PKG II (Km = 305 μM).
-
BI-0474
BI-0474 is a potent KRASG12C inhibitor that inhibits GDP-KRAS::SOS1 protein-protein interactions with an IC50 value of 7.0 nM.BI-0474 exhibits significant antiproliferative activity against NCI-H358 cells harboring the G12C mutation, and shows significant anti-tumor activity in a non-small cell lung cancer xenograft model.
Cart
sales@molnova.com